635714-19-1

Basic information

• Product Name: L-Alanine, N-[(1,1-dimethylethoxy)carbonyl]-3-[[(2-nitrophenyl)sulfonyl]amino]-, methyl ester
• CAS NO: 635714-19-1
• Molecular Formula: C15H21N3O8S
• Molecular Weight: 403.413
• Mol File: 635714-19-1.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: L-Alanine, N-[(1,1-dimethylethoxy)carbonyl]-3-[[(2-nitrophenyl)sulfonyl]amino]-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: L-Alanine, N-[(1,1-dimethylethoxy)carbonyl]-3-[[(2-nitrophenyl)sulfonyl]amino]-, methyl ester(635714-19-1)
• EPA Substance Registry System: L-Alanine, N-[(1,1-dimethylethoxy)carbonyl]-3-[[(2-nitrophenyl)sulfonyl]amino]-, methyl ester(635714-19-1)

Safety Data

• Hazardous Substances Data: 635714-19-1(Hazardous Substances Data)

Upstream product

• 186581-53-3 diazomethane 
• 76387-70-7 (S)-3-amino-2-tert-butoxycarbonylaminopropionic acid 
• 61040-20-8 (S)-methyl 3-amino-2-((tert-butoxycarbonyl)amino)propanoate 
• 1694-92-4 2-Nitrobenzenesulfonyl chloride 

Downstream Products

• 1338649-92-5 2-amino-3-[(2-nitro-benzenesulfonyl)-pent-4-enylamino]propionic acid methyl ester 
• 1338649-93-6 2-cyclopentyloxycarbonylamino-3-[(2-nitro-benzenesulfonyl)-pent-4-enyl-amino]propionic acid methyl ester 
• 1338650-23-9 2-cyclopentyloxycarbonylamino-3-[(2-nitro-benzenesulfonyl)-pent-4-enyl-amino]propionic acid 
• 1338650-07-9 1-[(4-(4-bromobenzenesulfonyloxy)-1-{2-cyclopentyloxycarbonylamino-3-[(2-nitro-benzenesulfonyl)pent-4-enyl-amino]propionyl}pyrrolidine-2-carbonyl)amino]-2-vinylcyclopropanecarboxylic acid ethyl ester 
• 790305-07-6 2(S)-(tert-butoxycarbonylamino)-3-(2-nitro-N-(pent-4-enyl)phenylsulfonamido)propanoic acid 
• 790305-06-5 2-tert-butoxycarbonylamino-3-[(2-nitro-benzenesulfonyl)-pent-4-enyl-amino]propionic acid methyl ester 
• 635714-20-4 3-[allyl-(2-nitrobenzenesulfonyl)amino]-2-tert-butoxycarbonylaminopropionic acid methyl ester 

Relevant articles and documents

A concise synthesis of the HCV protease inhibitor BILN 2061 and its P3 modified analogs

A concise synthesis of BILN 2061 was achieved through more efficient installation of P2 4-quinoline moiety via SN2 displacement of the β-OBs group located on the 4-hydroxyl proline intermediate, which was prepared from 4-α-hydroxyl proline analog via Mitsunobu reaction with inversion of stereochemistry. In addition, a short and practical synthesis for P3 unit is also described herein. Final assembly of four fragments for BILN 2061 was achieved with an overall yield of 58% in 4 steps from P1 to 15a. Furthermore several analogs of BILN 2061 (WX-1-WX-5) containing modifications on P3 unit were synthesized successfully using the same synthetic route as described for the parent inhibitor BILN 2061. Copyright

MACROCYCLIC PEPTIDES AS HEPATITIS C VIRUS INHIBITORS

Macrocyclic peptides having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

NOVEL INTERLEUKIN-1β CONVERTING ENZYME INHIBITORS

The present invention relates to novel compounds, compositions comprising said compounds, and uses thereof, said compounds having the formula (a). X is -CH2-, -O- or -NR9-;R is a carbocyclic or heterocyclic ring;R1 is a cy